Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol
The experimentally established mechanism targets of Nimorazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 known ✓ | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nimorazole SCHEMBL2555550 | 1.00 | KMT2A (0.38) | KMT2AMEN1POLBHRH4HRH3 | |
| Nimorazole SCHEMBL2558233 | 1.00 | KMT2A (0.38) | KMT2AMEN1POLBHRH4HRH3 | |
| Nimorazole SCHEMBL21836 | 0.90 | KMT2A (0.45) | KMT2AMEN1POLBALDH1A1SMN1; SMN2 | |
| Nimorazole SCHEMBL2549842 | 0.89 | GLA (0.46) | KMT2AMEN1POLBALDH1A1KDM4E | |
| Nimorazole SCHEMBL2555788 | 0.89 | POLB (0.44) | KMT2AMEN1POLBALDH1A1KDM4E | |
| Nimorazole SCHEMBL2552501 | 0.87 | GLA (0.43) | KMT2AMEN1POLBALDH1A1KDM4E | |
| Nimorazole SCHEMBL2552669 | 0.86 | MEN1 (0.40) | KMT2AMEN1POLBALDH1A1SMN1; SMN2 | |
| Nimorazole SCHEMBL2556141 | 0.86 | PKM (0.43) | KMT2AMEN1POLBALDH1A1KDM4E | |
| Nimorazole SCHEMBL2557042 | 0.86 | ALDH1A1 (0.39) | KMT2AMEN1POLBALDH1A1KDM4E | |
| Nimorazole SCHEMBL2555557 | 0.85 | KMT2A (0.47) | KMT2AMEN1ALDH1A1KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130096123-A1 | RADIATION SENSITISER COMPOSITIONS | EUPHARMA PTY LTD (AU) | 2013-04-18 | — | — | US | claimed |
| EP-2558090-A1 | RADIATION SENSITISER COMPOSITIONS | Eupharma Pty Ltd (AU) | 2013-02-20 | — | — | EP | claimed |
| CN-102933213-A | Radiation sensitiser compositions | EUPHARMA PTY LTD | 2013-02-13 | — | — | CN | claimed |
| WO-2011127537-A1 | RADIATION SENSITISER COMPOSITIONS | PHEBRA PTY LTD (AU) | 2011-10-20 | — | — | WO | claimed |